...
首页> 外文期刊>Chemistry central journal >Enhanced preferential cytotoxicity through surface modification: synthesis, characterization and comparative in vitro evaluation of TritonX-100 modified and unmodified zinc oxide nanoparticles in human breast cancer cell (MDA-MB-231)
【24h】

Enhanced preferential cytotoxicity through surface modification: synthesis, characterization and comparative in vitro evaluation of TritonX-100 modified and unmodified zinc oxide nanoparticles in human breast cancer cell (MDA-MB-231)

机译:通过表面修饰增强优先细胞毒性:TritonX-100修饰和未修饰的氧化锌纳米粒子在人乳腺癌细胞中的合成,表征和体外比较评估(MDA-MB-231)

获取原文
           

摘要

Background Nanoparticles (NPs) are receiving increasing interest in biomedical research owing to their comparable size with biomolecules, novel properties and easy surface engineering for targeted therapy, drug delivery and selective treatment making them a better substituent against traditional therapeutic agents. ZnO NPs, despite other applications, also show selective anticancer property which makes it good option over other metal oxide NPs. ZnO NPs were synthesized by chemical precipitation technique, and then surface modified using Triton X-100. Comparative study of cytotoxicity of these modified and unmodified NPs on breast cancer cell line (MDA-MB-231) and normal cell line (NIH 3T3) were carried out.
机译:背景技术由于纳米粒子(NPs)的大小与生物分子相当,新颖的特性以及易于用于靶向治疗,药物递送和选择性治疗的表面工程技术,因此越来越引起人们对生物医学研究的兴趣,这使其成为传统治疗剂的较好取代基。尽管有其他应用,但ZnO NPs也显示出选择性的抗癌性能,使其成为优于其他金属氧化物NPs的良好选择。 ZnO NPs通过化学沉淀技术合成,然后使用Triton X-100进行表面改性。进行了这些修饰的和未修饰的NP对乳腺癌细胞系(MDA-MB-231)和正常细胞系(NIH 3T3)的细胞毒性的比较研究。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号